Liver involvement in rheumatic diseases.

Area of Science:

• Rheumatology
• Hepatology
• Clinical Medicine

Background:

• Rheumatic diseases can present with liver involvement, including primary liver conditions, hepatic manifestations of rheumatic disorders, or drug-induced liver injury.
• Elevated liver enzymes in rheumatic patients necessitate careful evaluation to rule out underlying liver diseases or medication side effects.

Purpose of the Study:

• To emphasize the importance of monitoring aminotransferases and cholestatic enzymes in patients with rheumatic disorders.
• To highlight the need for investigating persistently elevated liver enzymes for concomitant autoimmune liver diseases or drug hepatotoxicity.
• To raise awareness of potential hepatitis B reactivation or hepatitis C flare-ups with immunosuppressant use.

Main Methods:

• Review of clinical presentations and diagnostic considerations for liver involvement in rheumatic diseases.
• Analysis of the significance of monitoring liver function tests (LFTs) in this patient population.
• Discussion of differential diagnoses including autoimmune liver diseases and drug-induced liver injury.

Main Results:

• Elevated liver enzymes in rheumatic disorders warrant investigation for primary autoimmune liver diseases (autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis).
• Drug-induced liver injury is a significant concern in patients treated for rheumatic conditions.
• Immunosuppressive therapy in rheumatic diseases carries a risk of hepatitis B reactivation and hepatitis C flare.

Conclusions:

• Regular monitoring of liver enzymes is essential for early detection of liver complications in rheumatic diseases.
• A high index of suspicion for autoimmune liver disease and drug hepatotoxicity is required in rheumatic patients with abnormal LFTs.
• Vigilance for viral hepatitis reactivation is critical when initiating or managing immunosuppressive treatments in rheumatology.